Form Of Senior Secured Convertible Promissory Note Sample Contracts

Share Cite Term
Link

Embed (HTML)
Anthera Pharmaceuticals – Form of Senior Secured Convertible Promissory Note (January 29th, 2010)

For value received Anthera Pharmaceuticals, Inc., a Delaware corporation (Payor or the Company) promises to pay to or its assigns (Holder) the principal sum of $ with simple interest on the outstanding principal amount at the rate of Eight Percent (8%) per annum (the Interest). Interest shall commence with the date hereof and shall continue on the outstanding principal until paid in full or converted. Interest shall be computed on the basis of a year of 365 days for the actual number of days elapsed. Unless otherwise defined herein, defined terms in this note (the Note) shall have the meanings ascribed to them in that certain Note Purchase Agreement, dated as of December 11, 2009, by and among the Company and the persons or entities listed on the Schedule of Purchasers attached thereto (the Purchase Agreement).

Anthera Pharmaceuticals – Form of Senior Secured Convertible Promissory Note (January 29th, 2010)

For value received Anthera Pharmaceuticals, Inc., a Delaware corporation (Payor or the Company) promises to pay to or its assigns (Holder) (i) the principal sum of $ (the Principal Amount), (ii) previously accrued interest on the Principal Amount in the amount of $ (the Accrued Interest), and (iii) simple interest on the outstanding Principal Amount at the rate of Eight Percent (8%) per annum (the Interest). Interest shall commence with the date hereof and shall continue on the outstanding principal until paid in full or converted. Interest shall be computed on the basis of a year of 365 days for the actual number of days elapsed. Unless otherwise defined herein, defined terms in this note (the Note) shall have the meanings ascribed to them in that certain Note Purchase Agreement, dated as of December 11, 2009, by and among the Company and the persons or entiti

Anthera Pharmaceuticals – Form of Senior Secured Convertible Promissory Note (September 15th, 2009)

For value received Anthera Pharmaceuticals, Inc., a Delaware corporation (Payor or the Company) promises to pay to ______or its assigns (Holder) the principal sum of $______ with simple interest on the outstanding principal amount at the rate of Eight Percent (8%) per annum (the Interest). Interest shall commence with the date hereof and shall continue on the outstanding principal until paid in full or converted. Interest shall be computed on the basis of a year of 365 days for the actual number of days elapsed. Unless otherwise defined herein, defined terms in this note (the Note) shall have the meanings ascribed to them in that certain Note and Warrant Purchase Agreement, dated as of July 17, 2009, by and among the Company and the persons or entities listed on the Schedule of Purchasers attached thereto (the Purchase Agreement).

Genta – GENTA INCORPORATED Form of Senior Secured Convertible Promissory Note Due June ____, 2010 (June 10th, 2008)

For value received, GENTA INCORPORATED, a Delaware corporation (the Maker), hereby promises to pay to the order of _______________________ (together with its successors and representatives, the Holder), in accordance with the terms hereinafter provided, the principal amount of ________________________ ($______________), together with interest thereon. Pursuant to the Purchase Agreement (as defined in Section 1.1 hereof), the Maker has issued, is issuing or may in the future issue separate senior secured convertible promissory notes in substantially the same form as this Note (the Other Notes and collectively with this Note, the Notes) to separate purchasers (Other Holders and collectively with the Holder, the Holders).

Vubotics Inc. – Vubotics, Inc. Form of Senior, Secured, Convertible Promissory Note (September 4th, 2007)

FOR VALUE RECEIVED, and upon and subject to the terms and conditions set forth herein, VuBotics, Inc., a Georgia corporation (Issuer), hereby promises to pay to the order of , a (together with its permitted successors and assigns, Holder), the principal sum of UNITED STATED DOLLARS (U.S. $ ) on the Maturity Date, together with interest as provided herein. This Note was issued under and is subject to a Securities Purchase Agreement (the Purchase Agreement) dated as of August 28, 2007 among Issuer, payee and certain other parties. Capitalized terms used and not otherwise defined herein will have the respective meanings given to such terms in the Purchase Agreement.